GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medipharco Pharmaceutical JSC (HSTC:MTP) » Definitions » Equity-to-Asset

Medipharco Pharmaceutical JSC (HSTC:MTP) Equity-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2010. Start your Free Trial

What is Medipharco Pharmaceutical JSC Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Medipharco Pharmaceutical JSC's Total Stockholders Equity for the quarter that ended in . 20 was ₫0.00 Mil. Medipharco Pharmaceutical JSC's Total Assets for the quarter that ended in . 20 was ₫0.00 Mil.

The historical rank and industry rank for Medipharco Pharmaceutical JSC's Equity-to-Asset or its related term are showing as below:

HSTC:MTP's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.6
* Ranked among companies with meaningful Equity-to-Asset only.

Medipharco Pharmaceutical JSC Equity-to-Asset Historical Data

The historical data trend for Medipharco Pharmaceutical JSC's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipharco Pharmaceutical JSC Equity-to-Asset Chart

Medipharco Pharmaceutical JSC Annual Data
Trend
Equity-to-Asset

Medipharco Pharmaceutical JSC Semi-Annual Data
Equity-to-Asset

Competitive Comparison of Medipharco Pharmaceutical JSC's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Medipharco Pharmaceutical JSC's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipharco Pharmaceutical JSC's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medipharco Pharmaceutical JSC's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Medipharco Pharmaceutical JSC's Equity-to-Asset falls into.



Medipharco Pharmaceutical JSC Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Medipharco Pharmaceutical JSC's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )=Total Stockholders Equity/Total Assets
=/
=

Medipharco Pharmaceutical JSC's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )=Total Stockholders Equity/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medipharco Pharmaceutical JSC  (HSTC:MTP) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Medipharco Pharmaceutical JSC Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Medipharco Pharmaceutical JSC's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipharco Pharmaceutical JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
08 Nguyen Truong to Street, Phuoc Vinh Ward, Thien Hue Province, Hue, VNM
Medipharco Pharmaceutical JSC is engaged in manufacturing, trading, and import-export medicines, medical equipment, and supplies, cosmetic products, sanitary products, biological products, essential oils, aromatherapy. Its products consist of Betamethason, Gentameson, Neutasol, Mediclovir, Rhumenol flu 500, and Clotrimazol among others.

Medipharco Pharmaceutical JSC Headlines

No Headlines